Carnahan Karen L was awarded 18 derivative securities of Cintas Corp at $198.95 per share, leaving her post-transaction holding at 6,834. The award represents about 0.3% of that resulting position, giving investors a precise view of the director’s newly recorded derivative-security interest.
Key Highlights
- Karen Carnahan L is identified as a director of Cintas Corp.
- The transaction occurred on 15 September 2026.
- Transaction code A classifies the entry as an award or grant.
Carnahan Karen L received 18 derivative securities of Cintas Corp (NASDAQ: CTAS) at $198.95 per share on 15 September 2026, with her resulting position recorded at 6,834 derivative securities. The award represents about 0.3% of that post-transaction holding. Karen Carnahan L is identified as a director of Cintas Corp.
Cintas Award Priced at $198.95
Each of the 18 securities carried a reported price of $198.95 per share. The record places the transaction on 15 September 2026 and identifies Cintas Corp as the related company. Karen Carnahan L’s position after the transaction was 6,834 derivative securities. That figure is the resulting holding associated with the reported award. The transaction was recorded under Karen Carnahan L’s name.
FAQs
Q: How many Cintas derivative securities did Carnahan Karen L receive?
A: Carnahan Karen L received 18 derivative securities of Cintas Corp. The reported price was $198.95 per share.
Q: What was the value of Carnahan Karen L’s resulting derivative-securities holding?
A: The reported resulting holding was 6,834 derivative securities. The transaction represented about 0.3% of that position.
Q: When did Carnahan Karen L receive the Cintas derivative securities?
A: Carnahan Karen L received the Cintas derivative securities on 15 September 2026. The record identifies Cintas Corp as the related company.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.